A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2013
11/27/2013	CN103405746A Gel capable of fast removing acne
11/27/2013	CN103059099B Novel pidotimod crystal form and preparation method thereof
11/27/2013	CN102558298B Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers
11/27/2013	CN102516397B Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine
11/27/2013	CN102512656B Quinapril hydrochloride medicinal composition
11/27/2013	CN102219835B Long peptide based on HCA587 antigen and its application in preparing antitumor drugs
11/27/2013	CN102197044B Peptide having anti-diabetic activity and use thereof
11/27/2013	CN101842385B Food material for inhibiting formation of osteoclast
11/26/2013	US8592552 Antiviral peptides from african swine fever virus which prevent the binding of the virus to DLC8
11/26/2013	US8592551 Biomolecular recognition of crystal defects
11/26/2013	US8592379 Metastin derivative and use thereof
11/26/2013	US8592378 Compound WS 727713
11/26/2013	US8592377 Stitched polypeptides
11/26/2013	US8592376 Hair care compositions
11/26/2013	US8592375 Multifunctional context-activated protides and methods of use
11/26/2013	US8592374 Neurotrophic peptides
11/26/2013	US8592373 Methods for prevention and treatment of acute renal injury
11/26/2013	US8592372 Pharmaceutical composition and method of use to improve organ function
11/26/2013	US8592370 Combination of insulin with triazine derivatives
11/26/2013	US8592369 Lactoferrin and gut neuronal health in adults and/or elderly
11/26/2013	US8592368 JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
11/26/2013	US8592367 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same
11/26/2013	US8592366 Peptide pharmaceutical for oral delivery
11/26/2013	US8592365 Spacer moiety for poly(ethylene glycol) modified peptide based compounds
11/26/2013	US8592364 CCR7 ligand delivery and co-delivery in immunotherapy
11/26/2013	US8592363 ψεrack peptide composition and method for protection against tissue damage due to ischemia
11/26/2013	US8592193 High activity mutants of butyrylcholinesterase for cocaine hydrolysis
11/26/2013	US8592174 Peptidase substrates
11/26/2013	US8592166 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
11/26/2013	US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
11/26/2013	US8592142 Analysis of amino acid copolymer compositions
11/26/2013	US8591953 Drug carrier and drug carrier kit for inhibiting fibrosis
11/26/2013	US8591943 Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors
11/26/2013	US8591933 Temporal release of growth factors from 3D micro rod scaffolds for tissue regeneration
11/26/2013	US8591913 Methods of decreasing adipose tissue
11/26/2013	US8591910 Chemically programmable immunity
11/26/2013	US8591907 Hypoallergenic variants of the major allergen from Betula verrucosa pollen
11/26/2013	US8591906 Immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis
11/26/2013	US8591903 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
11/26/2013	US8591890 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/26/2013	US8591887 EPHA2 as a therapeutic target for cancer
11/26/2013	US8591884 Compositions and methods for enhancing metal ion dependent drug therapies
11/26/2013	US8591878 Therapeutic compounds
11/26/2013	CA2747029C Spinning impingement multiphase contacting device
11/26/2013	CA2663584C Composition and method for treating iron deficiency anemia
11/26/2013	CA2661892C Gel type enteral nutrient
11/26/2013	CA2610361C Combination of 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine and a second active agent and use thereof for plasma glucose control
11/26/2013	CA2603518C Nutrient composition for promoting collagen production
11/26/2013	CA2564868C Methods for treating or preventing restenosis and other vascular proliferative disorders
11/26/2013	CA2561565C Methods for repression of phospholamban gene and modulating cardiac contractility
11/26/2013	CA2542054C Use of somatostatin or one of the analogs thereof for producing a medicament serving to regulate the ovarian follicular reserve in non-menopausal women
11/26/2013	CA2511538C Immunostimulatory combinations
11/26/2013	CA2457918C Mullerian inhibiting substance levels and ovarian response
11/26/2013	CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013	CA2448971C Chimeric flavivirus vectors
11/26/2013	CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/26/2013	CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013	CA2279231C Activity dependent neurotrophic factor iii (adnf iii)
11/26/2013	CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/21/2013	WO2013173827A2 Methods and compositions for inhibiting diseases of the central nervous system
11/21/2013	WO2013173807A1 Improved mobilization of hematopoetic stem cells from bone marrow to blood using a combination of a robo4 receptor antagonist and a cxcr4 antagonist or hrvegf-165 and a cxcr4 antagonist
11/21/2013	WO2013173730A2 Novel therapeutic uses of mu-opiate receptor peptides
11/21/2013	WO2013173678A1 COMPOSITIONS WHICH REGULATE THE EPITHELIAL BRUSH BORDER Na+/H+ EXCHANGER NHE3 AND THEIR METHODS OF USE IN GASTROINTESTINAL DISEASE
11/21/2013	WO2013173590A1 Vaccines for hsv-2
11/21/2013	WO2013173512A2 High-transduction-efficiency raav vectors, compositions, and methods of use
11/21/2013	WO2013173417A2 Glucokinase activator compositions for the treatment of diabetes
11/21/2013	WO2013173411A1 Cancer stem cell targeted cancer vaccines
11/21/2013	WO2013173393A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013	WO2013173391A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013	WO2013173309A1 Recombinant auto-activating protease precursors
11/21/2013	WO2013173180A2 Histatin for corneal wound healing and ocular surface disease
11/21/2013	WO2013173158A1 Therapeutic uses of fibroblast growth factor 21 proteins
11/21/2013	WO2013172956A1 Methods for limiting development of a skin wound
11/21/2013	WO2013172838A1 Compositions and methods for hair growth
11/21/2013	WO2013172728A1 Agent for correcting metabolic syndrome
11/21/2013	WO2013172721A1 Combination treatments and compositions for wound healing
11/21/2013	WO2013172517A1 Bone loss preventing and bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide
11/21/2013	WO2013172472A1 Sheet molding and hemostatic material
11/21/2013	WO2013172468A1 Sterilized composition
11/21/2013	WO2013172467A1 Radiation-sterilization-resistant protein composition
11/21/2013	WO2013171595A1 Novel compounds and methods for inhibiting cell death
11/21/2013	WO2013171570A1 Polypeptide loaded poca nanoparticles for oral administration
11/21/2013	WO2013171515A1 Methods and groups
11/21/2013	WO2013171233A1 Use of cacybp/sip in the treatment and diagnosis of alzheimer's disease
11/21/2013	WO2013171055A1 Method for the in vitro maturation of dendritic cells.
11/21/2013	WO2013170960A1 Use of vegfr1 as a biomarker for pkn3 inhibitor administration
11/21/2013	WO2013170636A1 Protein and protein conjugate for diabetes treatment, and applications thereof
11/21/2013	WO2013170408A1 Tat ptd-endostatin recombinant protein, preparation method and application thereof
11/21/2013	WO2013170386A1 Oligonucleotide chelate complex-polypeptide compositions and methods
11/21/2013	WO2013170367A1 Methods and uses for proprotein convert ase subtilisin kexin 9 (pcsk9) inhibitors
11/21/2013	WO2013170365A1 Compositions of sparc polypeptide and grp78, and methods and uses thereof for sensitizing cancer cells
11/21/2013	WO2013170364A1 Sparc polypeptide and collagen-iv matrix for sensitizing cancer cells to a chemotherapeutic agent
11/21/2013	WO2013170315A1 A method of treatment and agents useful for same
11/21/2013	WO2013142449A9 Treatment for chronic pain syndromes
11/21/2013	WO2013136175A3 Repeat variable diresidues for targeting nucleotides
11/21/2013	WO2013129935A4 Use of a particulate immunomodulator in cancer therapy
11/21/2013	WO2013128419A3 Pharmaceutical compositions comprising boronic acid compounds
11/21/2013	WO2013119144A3 Hair growth agent (embodiments) and method for treating hair loss
11/21/2013	WO2013113916A3 Ghrelin analogues
11/21/2013	WO2013096773A3 Methods, systems, and compositions for promoting recovery of peripheral neuropathy

1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 3163